Hospital
Villages Tri-County Medical Center INC.
Villages Tri-County Medical Center INC. was paid $2.88M by Medicaid between Jan 2018 and Dec 2024, across 88 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.
33Billing provider infoVILLAGES TRI-COUNTY MEDICAL CENTER INC.
THE VILLAGES, FL 32159
THE VILLAGES, FL 32159
33aNPI1275902124assigned 09/22/2015
33bProvider typeRehabilitation Hospital
28Total paid$2.88M
24GClaims100,774
24DCodes billed88
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,246 | $137K | |
| 2019 | 18,015 | $311K | |
| 2020 | 17,132 | $382K | |
| 2021 | 21,012 | $556K | |
| 2022 | 26,421 | $875K | |
| 2023 | 8,748 | $470K | |
| 2024incomplete | 2,200 | $150K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 9,682 | 8,672 | $905K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 7,505 | 6,254 | $481K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.5% | 2,540 | 2,339 | $187K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.8% | 1,753 | 1,461 | $166K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.2% | 1,631 | 1,291 | $150K |
| 81001 | 4.3% | 4,063 | 3,441 | $123K | |
| 80053 | Comprehensive metabolic panel | 4.1% | 7,198 | 5,281 | $118K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.1% | 2,045 | 1,329 | $118K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.7% | 543 | 467 | $108K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.1% | 431 | 393 | $90K |
| 36415 | Collection of venous blood by venipuncture | 2.9% | 2,412 | 1,419 | $84K |
| G0378 | Hospital observation service, per hour | 1.6% | 2,431 | 823 | $47K |
76 more codes
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.2% | 470 | $36K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 537 | $35K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,398 | $28K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 2,186 | $24K |
| A9270 | Non-covered item or service | <1% | 1,619 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,173 | $12K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 550 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,190 | $10K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 166 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,833 | $9K |
| 81025 | <1% | 1,572 | $9K | |
| 85610 | <1% | 2,905 | $9K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,874 | $9K |
| 94761 | <1% | 1,745 | $8K | |
| 87400 | <1% | 471 | $8K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 157 | $6K |
| 84484 | <1% | 2,880 | $6K | |
| 87081 | <1% | 693 | $5K | |
| 82962 | <1% | 1,090 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,750 | $5K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,140 | $5K |
| 85730 | <1% | 2,179 | $5K | |
| 94664 | <1% | 90 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 977 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 417 | $3K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 149 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,158 | $3K |
| J3490 | Unclassified drugs | <1% | 540 | $2K |
| 83735 | <1% | 1,413 | $2K | |
| 73610 | <1% | 115 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 80 | $2K |
| 83880 | <1% | 1,023 | $1K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 72 | $1K |
| 83690 | <1% | 1,879 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 307 | $1K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,010 | $1K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 30 | $1K |
| 73564 | <1% | 64 | $894.45 | |
| 87088 | <1% | 1,126 | $861.48 | |
| 96376 | <1% | 145 | $858.45 | |
| 84703 | <1% | 539 | $769.72 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 28 | $726.99 |
| 73630 | <1% | 74 | $686.70 | |
| 73130 | <1% | 42 | $561.23 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,178 | $541.86 |
| 73110 | <1% | 30 | $527.24 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 34 | $314.84 |
| 84100 | <1% | 110 | $307.43 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 406 | $239.78 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 138 | $219.56 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 440 | $212.29 |
| 87040 | <1% | 227 | $196.99 | |
| J2704 | Injection, propofol, 10 mg | <1% | 17 | $177.67 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 14 | $177.67 |
| 85379 | <1% | 68 | $146.06 | |
| 73030 | <1% | 18 | $125.30 | |
| 83605 | <1% | 144 | $121.01 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 259 | $81.18 |
| 87186 | <1% | 259 | $23.44 | |
| 80061 | Lipid panel | <1% | 17 | $10.29 |
| 86140 | <1% | 134 | $6.61 | |
| 82248 | 0% | 109 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 327 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 114 | $0.00 |
| 87420 | 0% | 185 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 14 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 16 | $0.00 |
| 84145 | 0% | 14 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 71 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 47 | $0.00 |
| 87077 | 0% | 129 | $0.00 | |
| 87807 | 0% | 43 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 21 | $0.00 |
| 82077 | 0% | 26 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 55 | $0.00 |
| J2770 | Injection, quinupristin/dalfopristin, 500 mg (150/350) | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLONG, HEATHER (CEO)
| Provider | Location | Paid |
|---|---|---|
| LRMC Urgent Care Center | Leesburg, FL | $11K |
| Leesburg Regional Medical Center Physician Services LLC | Leesburg, FL | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.